The PSA test: what men over 50 should know before and after

The PSA test is a blood test that measures prostate-specific antigen, a protein made by prostate tissue. A higher result can be associated with prostate cancer, but it can also occur for reasons unrelated to cancer, and a lower result does not rule cancer out. For men over 50, the decision to test is personal: discuss your risk, health, and preferences with a clinician before deciding, then ask what a result would mean before taking the test.

PSA testing is a screening conversation, not a diagnosis. A high result does not mean you have cancer, and screening can lead to repeat tests, imaging, biopsy, anxiety, or treatment of cancer that might never have caused harm. If you have urinary symptoms, blood in urine, bone pain, or another concerning change, discuss evaluation directly rather than relying on a screening test. New or worsening symptoms deserve medical care.

What PSA measures, and what it cannot tell you

PSA is a substance produced by prostate tissue. A blood test measures the amount in circulation. The number is one piece of information; it does not show by itself whether cancer is present, how serious a finding might be, or whether treatment would help. A clinician interprets the result alongside factors such as age, prior results, family history, ancestry, health conditions, and the reason for testing.

PSA can be elevated for reasons other than cancer, including benign prostate enlargement or inflammation. Results may vary over time. A result that is above a threshold is therefore a prompt for discussion and possible follow-up, not a final answer. The 2023 AUA/SUO guideline recommends PSA-based screening in the context of shared decision-making and describes tailored screening intervals based on risk. Guideline abstract

Before the test: questions to ask

Before testing, make sure you understand why it is being offered and what could happen next. Consider asking:

• What is my personal risk based on family history and other factors?
• What are the potential benefits and harms for someone with my health and life expectancy?
• If the result is higher than expected, what would the next step be?
• Would we repeat the blood test, use another risk assessment, or consider imaging before a biopsy?
• How might a diagnosis affect my quality of life, and what options could follow?
• If I decide not to test today, when should we revisit the decision?

Some groups have higher prostate cancer risk, including Black men and men with a close family history of prostate cancer. Tell the clinician about affected relatives and their age at diagnosis if you know it. Personal risk does not dictate one choice; it gives the discussion better context.

Guidelines differ in wording and are updated over time. A 2018 US Preventive Services Task Force statement concluded that men aged 55 to 69 should make an individual decision with a clinician after discussing benefits and harms, and recommended against routine screening for men 70 and older. It estimated a small potential benefit for some men in the younger group and highlighted false positives, biopsies, overdiagnosis, and treatment effects. USPSTF recommendation statement The AUA/SUO guideline published in 2023 also centers shared decision-making. Your clinician can apply current guidance to your circumstances.

How to think about the trade-off

Screening may find a cancer early enough to change the course for some people. But some prostate cancers grow slowly and would never have caused symptoms in a person’s lifetime. Finding them can lead to further testing and treatment, each with potential harms. The right choice depends on how you weigh a possible reduction in cancer risk against the chance of false alarms, procedures, side effects, and uncertainty.

The USPSTF’s evidence review reported that among men 55 to 69, screening programs may prevent about 1.3 prostate cancer deaths per 1,000 men screened over roughly 13 years, while also noting harms from false-positive results and treatment. The estimate describes populations, not an individual prediction. The statement also found the expected harms outweighed benefits for men 70 and older. USPSTF abstract

There is no obligation to accept a test because it is offered, and declining now does not mean you can never reconsider. A useful conversation makes room for your priorities, family history, and other health needs. If the clinician recommends a test, ask what specific information it will provide and how it might change care.

After the test: what happens next

If the result is not elevated, ask when to consider another test, if at all. A lower result can be reassuring in context, but it is not a lifetime guarantee. Keep a record of the date and number so future clinicians can compare results over time.

If the result is elevated, try not to jump to a conclusion. Ask the clinician to explain the level, compare it with any earlier results, and describe the range of next steps. Depending on your history and the result, they may recommend repeating the PSA, checking other risk factors, using an additional test, ordering imaging, or referring you to a urologist. A biopsy is not automatically the immediate next step for every elevated result.

Before a biopsy, ask what it can and cannot tell you, how it is performed, and about possible complications. If cancer is found, ask whether the features suggest a low-risk cancer that can be monitored, or a cancer for which treatment is more likely to be discussed. Decisions can involve several clinicians and more than one appointment. You can ask for time to understand options.

If you are uncertain or feel rushed, say so. Ask for the result and plan in writing, and consider a second opinion for major decisions. Keep track of follow-up appointments so an abnormal result is not lost between visits. At the same time, remember that a raised PSA is not itself a cancer diagnosis.

PSA and urinary symptoms are different conversations

The PSA test screens for prostate cancer risk. It is not a general test for why you have a weak stream, urgency, nighttime urination, or a feeling of incomplete emptying. Those symptoms can have several explanations, including benign prostate enlargement, bladder changes, medicines, infection, and sleep issues. Tell a clinician about symptoms separately so they can evaluate them on their own merits.

If urinary changes are new, worsening, painful, or disruptive, arrange medical care whether or not you have had a PSA test. Blood in urine, inability to urinate, severe pain, or fever with urinary symptoms calls for prompt assessment. New or worsening symptoms deserve medical care.

What about supplements?

Prostate supplements do not replace PSA screening discussions or medical evaluation. Research on commonly marketed ingredients is mixed. Saw palmetto, for example, has a large evidence base but a 2023 Cochrane review found little to no benefit for urinary symptoms. Supplements should not be represented as screening for cancer or as a way to interpret a PSA result. Cochrane review

Our prostate supplement comparison guide evaluates labels and the urinary symptom evidence. TitanFlow is the top-scoring product we reviewed in that category, at 3.6 out of 5. That is a middle score: pygeum is present at an amount used in a study, but beta-sitosterol and lycopene are below studied amounts, and there is no published trial of the full formula. Our scores are strict, and most products scored low. Read the TitanFlow review. Results vary. Talk to your doctor, especially with medications, before using a supplement. New or worsening symptoms deserve medical care.

FAQ

Does an elevated PSA mean I have prostate cancer?

No. PSA can be elevated for reasons other than cancer. A clinician interprets the result with your history and may recommend repeat or additional evaluation.

Can a normal PSA rule out prostate cancer?

No test result offers certainty by itself. Discuss what your result means for your risk and when any follow-up is appropriate.

Should every man over 50 get a PSA test?

There is no one answer for every man. Guidelines emphasize weighing potential benefits and harms with a clinician, considering age, risk, health, and personal preferences.

What if my PSA result is high?

Ask what the number means in context and what follow-up is appropriate. A high result is not a diagnosis, and a biopsy is not automatic in every case.

Is PSA testing the same as checking urinary symptoms?

No. PSA screening assesses prostate cancer risk. Urinary symptoms need their own evaluation because they can have several causes.

Can supplements lower my PSA or prevent prostate cancer?

Do not rely on supplements to interpret PSA or make cancer prevention claims. Discuss test results and supplements with your clinician, especially if you take medications.